Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The second-line ADMs included GLP1-R agonists, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, or sodium-glucose cotransporter 2 (SGLT2) inhibitors
They can evaluate whether a dose adjustment is needed, address any side effects affecting your progress, or recommend tweaks to your routine
Benefits can include: Lower blood pressure Lower total cholesterol Better liver health for those with metabolic dysfunctionassociated steatotic liver disease (MASLD) Lower blood sugar and reduced diabetes risk Lower risk of kidney disease Tirzepatide and orforglipron are newer drugs that dont yet have results from long-term cardiovascular health trials
Ultimately, the best option is the one that fits your health goals, preferences, and lifestyle
You can call or send emails to connect with these experts to have your queries resolved at absolutely no cost
